Icahn Stands by Offer for Mylan
303057
Wall Street financier Carl Icahn on Wednesday reaffirmed his offer to acquire the remaining shares of Mylan Laboratories Inc.  he did not already own for &#36;4.9 billion.
21639
CINCINNATI -- Billionaire investor Carl Icahn, known for challenging the management of various corporations, wants to acquire up to $500 million worth of additional shares of Federated Department Stores Inc. , the operator of Macy's and Bloomingdale's said yesterday .
675205
Billionaire investor Carl Icahn filed a federal lawsuit against Mylan Laboratories Inc. and asset manager Richard C. Perry on Monday, accusing Perry of a vote-buying scheme intended to help Mylan acquire King Pharmaceuticals Inc.
580086
WASHINGTON (CBS.MW) -- Mylan Laboratories (MYL) , responding to the latest in a series of letters from investor Carl Icahn, reasserted its position that acquiring King Pharmaceuticals (KG) is in the long-term interest of the generic drugmaker and its
613825
Billionaire financier Carl Icahn charged ahead on Monday with a $49 per share offer for New York office landlord Reckson Associates Realty Corp.  although his two partners withdrew from the bidding.
105149
By MIKE CRISSEY, Associated Press Writer, The Associated Press. Icahn, one of the 1980s most prolific corporate raiders, bought 18.
240592
Billionaire investor Carl Icahn on Tuesday weighed into the bidding fray for Hollywood Entertainment Corp. (HLYW.O: Quote, Profile, Research) , saying he supports a merger between the No.
392221
Financier Carl Icahn ended his bid for  Reckson Associates Realty Corp. , the Wall Street Journal  reported on its Web site on Tuesday, a move that illustrates  the difficulty activist shareholders face in challenging  management.
131989
A Mylan Laboratories shareholder is suing the Canonsburg generic drug maker and its directors, saying they have failed their fiduciary obligations by not considering billionaire investor Carl Icahn&#39;s $20 per share offer for the company.
588024
Financier Carl Icahn on Friday offered to buy the shares of generic drugmaker Mylan Laboratories  that he does not already own for &#36;4.9 billion, or &#36;20 a share, according to a government filing.
608996
Generic drug maker Mylan Laboratories Inc.  said on Friday it is raising at least about $993.6 million in a public offering of notes and common shares, with proceeds intended for global operations and potential acquisitions.
326818
Financier Carl Icahn on Monday said King Pharmaceutical Inc.&#39;s (KG) possible need to restate earnings reinforces his belief that an acquisition of King by Mylan Laboratories Inc.
357838
The billionaire financier Carl Icahn offered to buy the generic drug maker Mylan Laboratories to force the company to drop its acquisition of King Pharmaceuticals.
97449
Investor Carl Icahn on Thursday detailed his objections to Mylan Laboratories Inc.&#39;s proposed $4 billion acquisition of King Pharmaceuticals Inc.
404301
Mylan Laboratories Inc., the largest US maker of generic drugs, cautioned investors Friday that Thursday&#39;s jump in share price was likely driven by investor Carl Icahn&#39;s clearance to buy a large amount of company stock and fails to reflect &quot;negative ...
761363
Temple-Inland Inc. TIN.N on Friday  said Wall Street financier Carl Icahn and one of his funds  filed for clearance to buy up to $1 billion, or a little more  than a quarter, of the company's common stock.
161270
Billionaire investor Carl Icahn said on   Thursday he is seeking approval from shareholders of ImClone   Systems Inc. IMCL.O to remove six directors from its board,   including the chairman and the interim chief executive, and   bring in one of his own nominees.